Our service offerings are centered on three main pillars.
We assist investors, including private equity firms, investment banks, and pharmaceutical companies, in maximizing the value of their investments and avoiding the waste of time and money on non-valuable ventures.
We support Pharmaceutical Companies and CDMOs in identifying and selecting the most suitable partners, with a specific focus on complex products and niche technologies.
We provide expert advisory services for defining and executing pharmaceutical development programs.
We offer a broad range of services for healthcare players, including investors, pharmaceutical companies, CDMOs, associations, and incubators, across:
○ pharma and biotech
○ all markets, with a specific expertise with EMA and FDA regulations
○ small & large molecules ; medical devices
○ all dosage forms and routes of administration
Sell-side/Buy-side support
Site Acquisition/Divestment/Integration
Product/Dossier Acquisition/Divestment
Due Diligence
Investor Advisory & Fundraising
LCM – Asset/Product Life Cycle Management
Licensing
Market Study
Niche assets
Positioning & Diversification
Site & Culture Transformation
Business Intelligence
Prospection & Lead Generation
Conference Partnering
Negotiation & Contract Management
CDMO sourcing
RFQ management
Product Tech Transfer & Project Management
Complexity Management for Orphan & Rare Disease
Clinical Development
CMC
Health Authorities relation management (FDA / EMA)
Modified Release expertise
Patent / Intellectual Property management
Manufacturing & Packaging
Sustainable packaging
Capex & Investment
Lean Manufacturing – Continuous Improvement
Quality
Contact base of 3500+ names
Fundraising
Pharma & Biotech companies
CDMOs
KOL
Interim Management
Equipment & Facility suppliers
Incubators
Associations & Foundations
Connect with us today and discover how we can support you and add value to your projects.